Variant report
Variant | esv3471163 |
---|---|
Chromosome Location | chr11:77254238-77256158 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191178356 | chr11:77254239-77254240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs72943497 | chr11:77254266-77254267 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs560570674 | chr11:77254320-77254321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532675101 | chr11:77254355-77254356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183020552 | chr11:77254365-77254366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187472853 | chr11:77254367-77254368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190904446 | chr11:77254369-77254370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183147194 | chr11:77254377-77254378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187434124 | chr11:77254378-77254379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192240383 | chr11:77254384-77254385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12808816 | chr11:77254386-77254387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185151215 | chr11:77254388-77254389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188421763 | chr11:77254394-77254395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192554760 | chr11:77254395-77254396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556462080 | chr11:77254406-77254407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576261713 | chr11:77254410-77254411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535647033 | chr11:77254439-77254440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555070948 | chr11:77254440-77254441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574999739 | chr11:77254451-77254452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540751237 | chr11:77254519-77254520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560284899 | chr11:77254553-77254554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372151686 | chr11:77254651-77254652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554462277 | chr11:77254665-77254666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546142537 | chr11:77254672-77254673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111417756 | chr11:77254675-77254676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11602520 | chr11:77254720-77254721 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs140812471 | chr11:77254795-77254796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146006791 | chr11:77254823-77254824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552664596 | chr11:77254826-77254827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138908986 | chr11:77254833-77254834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562846990 | chr11:77254843-77254844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142933313 | chr11:77254920-77254921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570342823 | chr11:77254940-77254941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539428302 | chr11:77254972-77254973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188164363 | chr11:77254980-77254981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147244034 | chr11:77255038-77255039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569985383 | chr11:77255069-77255070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535608761 | chr11:77255082-77255083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73498854 | chr11:77255130-77255131 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs185041756 | chr11:77255148-77255149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138676203 | chr11:77255217-77255218 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34181714 | chr11:77255232-77255233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199748344 | chr11:77255256-77255257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs149352617 | chr11:77255286-77255287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12797573 | chr11:77255306-77255307 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs112742096 | chr11:77255312-77255313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116607042 | chr11:77255322-77255323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189387157 | chr11:77255323-77255324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182191780 | chr11:77255351-77255352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528376668 | chr11:77255358-77255359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21240255 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Breast cancer | 20932292 | CNVD |
Cancer | 20164920 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17142309 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Mental retardation | 17847001 | CNVD |
Melanoma | 19509136 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:77249200-77258600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr11:77252600-77254400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr11:77253200-77254600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr11:77253800-77259200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr11:77253800-77259200 | Weak transcription | HSMMtube | muscle |
6 | chr11:77253800-77259200 | Weak transcription | Osteobl | bone |
7 | chr11:77254000-77259200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
8 | chr11:77254400-77259200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr11:77254600-77259000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
10 | chr11:77255000-77255400 | Enhancers | Fetal Intestine Large | intestine |
11 | chr11:77255000-77255600 | Enhancers | Fetal Intestine Small | intestine |
12 | chr11:77255200-77255400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr11:77255400-77256600 | Weak transcription | Fetal Intestine Large | intestine |
14 | chr11:77255400-77258400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
15 | chr11:77255600-77258600 | Weak transcription | Fetal Intestine Small | intestine |